methasan 20 mg-tabletten
g.l. pharma gmbh - methadonhydrochlorid -
methasan 40 mg-tabletten
g.l. pharma gmbh - methadonhydrochlorid -
methasan 5 mg-tabletten
g.l. pharma gmbh - methadonhydrochlorid -
methasan 60 mg-tabletten
g.l. pharma gmbh - methadonhydrochlorid -
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastische mittel - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
voriconazol hameln 200 mg pulver zur herstellung einer infusionslösung
hameln pharma gmbh (8084054) - pulver zur herstellung einer infusionslösung - 200 mg